Location History:
- San Francisco, CA (US) (1997 - 2003)
- Chesterfield, MO (US) (2003 - 2006)
- Redwood City, CA (US) (1998 - 2009)
Company Filing History:
Years Active: 1997-2009
Title: The Innovative Contributions of Scott L. Weinrich
Introduction
Scott L. Weinrich is a prominent inventor based in Redwood City, California. He has made significant contributions to the field of biotechnology, particularly in the area of cancer research. With a total of 17 patents to his name, his work has had a profound impact on the development of therapeutic strategies.
Latest Patents
Among his latest patents is the invention of inhibitory polynucleotides directed against the RNA component of telomerase. This invention provides inhibitory polynucleotides, such as antisense molecules, directed against accessible regions in the telomerase ribonucleoprotein. The polynucleotides are useful for inhibiting the activity of telomerase in cells and for treating cancer. Another notable patent involves producing telomerase activators and inhibitors by screening with purified telomerase. This invention provides purified telomerase and methods of purifying it, involving several sequential steps, including the use of matrices that bind molecules bearing negative charges, matrices that bind molecules bearing positive charges, intermediate-selectivity matrices, and methods that separate molecules based on their size, shape, or buoyant density.
Career Highlights
Scott has worked with notable organizations such as Geron Corporation and the University of Texas System. His experience in these institutions has allowed him to advance his research and contribute to significant scientific advancements.
Collaborations
Throughout his career, Scott has collaborated with esteemed colleagues, including Nam Woo Kim and Calvin B. Harley. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Scott L. Weinrich's contributions to biotechnology and cancer research through his innovative patents highlight his role as a leading inventor in the field. His work continues to inspire advancements in therapeutic strategies and cancer treatment.